Histogen to Present at the Canaccord Genuity 41st Annual Growth Conference
Histogen Inc. (NASDAQ: HSTO), a clinical-stage therapeutics company, is set to present at the Canaccord Genuity 41st Annual Growth Conference on August 12, 2021, at 2:00 p.m. Eastern Time.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Histogen Inc. (NASDAQ: HSTO), a clinical-stage therapeutics company, is set to present at the Canaccord Genuity 41st Annual Growth Conference on August 12, 2021, at 2:00 p.m. Eastern Time. Richard W. Pascoe, President and CEO, will lead the presentation, which will focus on the company’s innovative restorative therapeutics aimed at enhancing biological function. For those unable to attend live, a replay will be available for 90 days on Histogen's investors page.
Details
News Market Reaction – HSTO
The recorded move for HSTO in the trading session of this news was +6.61%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
SAN DIEGO, July 29, 2021 (GLOBE NEWSWIRE) -- Histogen Inc. (NASDAQ: HSTO), a clinical-stage therapeutics company focused on developing potential first-in-class restorative therapeutics that ignite the body’s natural process to repair and maintain healthy biological function, today announced that Richard W. Pascoe, President and Chief Executive Officer of Histogen, will present at the Canaccord Genuity 41st Annual Growth Conference. The virtual presentation is scheduled for Thursday, August 12, 2021 at 2:00 p.m. Eastern Time.
Presentation Details
Date: Thursday, August 12, 2021
Time: 2:00 p.m. Eastern Time (11:00 a.m. Pacific Time)
Live Webcast Link: https://wsw.com/webcast/canaccord60/his/2247696
For those not available to listen to the live broadcast, a replay will be archived for 90 days and available through the Investors page on www.histogen.com.
About Histogen Inc.
Histogen Inc. is a clinical-stage therapeutics company focused on developing potential first-in-class restorative therapeutics that ignite the body’s natural process to repair and maintain healthy biological function. Histogen’s innovative technology platform utilizes cell conditioned media and extracellular matrix materials produced by hypoxia-induced multipotent cells. Histogen’s proprietary, reproducible manufacturing process provides targeted solutions across a broad range of therapeutic indications including joint cartilage regeneration, spinal disk repair, hair growth, and dermal rejuvenation. For more information, please visit www.histogen.com.
CONTACT:
Susan A. Knudson
Executive Vice President & CFO
Histogen Inc.
ir@histogen.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.